Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC, USA.
University of Virginia Morven Dialogues, USA.
Prev Med. 2020 Nov;140:106183. doi: 10.1016/j.ypmed.2020.106183. Epub 2020 Jun 27.
In this paper we have attempted to identify missed opportunities to change the trajectory of smoking and smoking caused diseases in America over the past 100 years. Many of the missed opportunities identified are due to the actions of cigarette manufacturers who misled the public about the dangers of cigarette smoking, the addictiveness of nicotine, and the feasibility of providing lower risk alternative nicotine delivery products to addicted smokers. An important lesson learned from the past is that treating all tobacco/nicotine products as equivalently harmful is counterproductive to public health as it only serves to protect the most lethal nicotine product - cigarettes. Since 2000, the evolving marketplace of lower risk nicotine products combined with regulatory authority over tobacco products represents a new opportunity to dramatically transform the cigarette business in ways that were never imagined when the war on tobacco was raging decades ago. However, this requires embracing risk-proportionate regulation, taxation policies, and providing consumers with accurate public messaging on product relative risks. A regulatory framework based on sound science that encourages and rewards new or existing manufacturers to invest in consumer acceptable lower risk products to replace cigarettes needs to be encouraged. The past is indeed not the future in smoking control, but it may be difficult to escape the past unless a realignment of market forces and policies can be achieved.
本文试图确定在过去 100 年中,美国在改变吸烟轨迹和吸烟相关疾病方面错失的机会。许多被确定的错失机会都归因于卷烟制造商的行为,他们在吸烟的危害、尼古丁的成瘾性以及提供低风险替代尼古丁产品给成瘾吸烟者的可行性方面误导了公众。过去吸取的一个重要教训是,将所有烟草/尼古丁产品视为同等有害,这对公共健康是适得其反的,因为这只会保护最致命的尼古丁产品——香烟。自 2000 年以来,低风险尼古丁产品不断变化的市场以及对烟草产品的监管权代表了一个新的机会,可以以前所未有的方式彻底改变卷烟业,而这在几十年前烟草战争激烈进行时是无法想象的。然而,这需要接受风险相称的监管、税收政策,并为消费者提供关于产品相对风险的准确公共信息。需要鼓励基于鼓励和奖励新的或现有的制造商投资于消费者可接受的低风险产品以替代香烟的基于健全科学的监管框架。在控烟方面,过去确实不是未来,但除非能够实现市场力量和政策的重新调整,否则可能难以摆脱过去。